Status:
COMPLETED
Non-Invasive Hemoglobin Study
Lead Sponsor:
Convergence Biometrics
Collaborating Sponsors:
DRMiller Engineering
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Brief Summary
The investigators clinical trials will be for a medical device that is non-invasive in nature. The investigators will be studying whether their non-invasive medical device gets data that is as good as...
Eligibility Criteria
Inclusion
- Inclusion criteria for this study are:
- Subject is capable of giving informed consent.
- Subject has an anatomically intact digit capable of having a capillary sample taken and of being placed in the POCT device.
- Exclusion criteria for this study are:
- Age less than 18 years at time of research
- Subject lacks the digits to place in the POCT device
- Subject displays symptoms or has a history of Raynaud's disease
- Subject has a neurological disorder resulting in an inability to hold the index finger steady for 20 sec.
- Subject has a history of long term continuous decreased perfusion to either hand (\>30 days).
- Subject has had surgery within the last 2 weeks on finger or hand that he wishes to use in the study
- Subject's same day participation in this study
- Capillary sample volume is not adequate to complete testing on the comparative device.
- Cold agglutinin disease
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
237 Patients enrolled
Trial Details
Trial ID
NCT02206399
Start Date
August 1 2014
End Date
November 1 2014
Last Update
June 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BloodSource
Sacramento, California, United States, 95655-4128